Nano-biomaterials for cardiovascular applications: Clinical perspective

Cicha I, Singh R, Garlichs CD, Alexiou C (2016)

Publication Type: Journal article

Publication year: 2016

Journal

Journal of Controlled Release Elsevier

Book Volume: 229

Pages Range: 23-36

DOI: 10.1016/j.jconrel.2016.03.015

Abstract

Cardiovascular diseases, including ischemic heart disease and stroke, are responsible for nearly 25% of all deaths worldwide. Globally, their prevalence continues to increase, in spite of enormous progress in cardiovascular diagnostics and therapy. For therapeutic and regenerative purposes, biomaterials promise solutions with multiple advantages over synthetic materials. Furthermore, their easy availability as nanoformulations recommends their application as drug carriers or protective nanoshells improving the biocompatibility of imaging agents. In this work, we review the most promising and clinically meaningful scientific reports with regard to (nano)biomaterials with particular focus on potential improvements of existing, and development of novel constructs for cardiovascular applications.

Authors with CRIS profile

Iwona Cicha Lehrstuhl für Innere Medizin II Christoph Alexiou Professur für Nanomedizin

Involved external institutions

Diakonissenkrankenhaus Flensburg DE Germany (DE)

How to cite

APA:

Cicha, I., Singh, R., Garlichs, C.D., & Alexiou, C. (2016). Nano-biomaterials for cardiovascular applications: Clinical perspective. Journal of Controlled Release, 229, 23-36. https://doi.org/10.1016/j.jconrel.2016.03.015

MLA:

Cicha, Iwona, et al. "Nano-biomaterials for cardiovascular applications: Clinical perspective." Journal of Controlled Release 229 (2016): 23-36.

BibTeX: Download